Peer Review reports
From: Prognostic significance and immune characteristics of CMTM4 in hepatocellular carcinoma
Original Submission | ||
---|---|---|
25 Nov 2021 | Submitted | Original manuscript |
15 Dec 2021 | Reviewed | Reviewer Report |
17 Dec 2021 | Reviewed | Reviewer Report |
29 Dec 2021 | Reviewed | Reviewer Report - Doureradjou Peroumal |
3 Jan 2022 | Reviewed | Reviewer Report |
18 Feb 2022 | Author responded | Author comments - Shengkui Tan |
Resubmission - Version 2 | ||
18 Feb 2022 | Submitted | Manuscript version 2 |
30 Mar 2022 | Reviewed | Reviewer Report |
7 Apr 2022 | Reviewed | Reviewer Report - Doureradjou Peroumal |
18 Jul 2022 | Author responded | Author comments - Shengkui Tan |
Resubmission - Version 3 | ||
18 Jul 2022 | Submitted | Manuscript version 3 |
31 Jul 2022 | Author responded | Author comments - Shengkui Tan |
Resubmission - Version 4 | ||
31 Jul 2022 | Submitted | Manuscript version 4 |
Publishing | ||
11 Aug 2022 | Editorially accepted | |
19 Aug 2022 | Article published | 10.1186/s12885-022-09999-y |
You can find further information about peer review here.